2023 Annual Meeting | C67 - Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

Date Sunday 04/23/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ruple S. Laughlin, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Through this case-based session, participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to: evaluate a weak patient to discern myopathy, neuromuscular junction, or motor neuron disorders; distinguish characteristics of peripheral neuropathy; and elucidate EDX findings in mononeuropathies and radiculopathies. The program will build upon electrodiagnostic knowledge acquired in Clinical EMG I.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Audience Participation

Event Timeline
03:30 PM - 03:35 PM EST	Introduction	Introduction Ruple S. Laughlin, MD, FAAN
03:35 PM - 04:05 PM EST	Speaker	EDX Case-Based Approach to Weakness Ruple S. Laughlin, MD, FAAN
04:05 PM - 04:45 PM EST	Speaker	Peripheral Neuropathy: Electrodiagnostic Cases Kelly G. Gwathmey, MD
04:45 PM - 05:20 PM EST	Speaker	EDX Cases: Plexopathies and Radiculopathies- How EDX Can Help Devon I. Rubin, MD, FAAN
05:20 PM - 05:30 PM EST	Discussion	Questions and Answers Devon I. Rubin, MD, FAAN, Ruple S. Laughlin, MD, FAAN, Kelly G. Gwathmey, MD

Faculty Disclosures
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Devon I. Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.